Wilkerson Advisory Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.75M Buy
1,463
+9
+0.6% +$9.2K 0.54% 30
2026
Q1
$1.34M Buy
1,454
+231
+19% +$234K 0.46% 34
2025
Q4
$1.31M Buy
+1,223
New +$1.17M 0.46% 33

Other funds holding LLY

Wilkerson Advisory Group's LLY Position: Q2 2026 in Review

Wilkerson Advisory Group increased its Eli Lilly (LLY) stake by 0.62% in Q2 2026, buying an estimated $9.2K and bringing the position to 1,463 shares worth $1.75M. The position accounts for 0.54% of the portfolio, ranked #30.

Wilkerson Advisory Group first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,614 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Wilkerson Advisory Group held 1,463 shares of Eli Lilly worth $1.75M as of Q2 2026.
  • Wilkerson Advisory Group bought 9 Eli Lilly shares in Q2 2026, an estimated $9.2K.
  • Eli Lilly made up 0.54% of Wilkerson Advisory Group's portfolio in Q2 2026, its #30 holding.
  • Wilkerson Advisory Group first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,614 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Wilkerson Advisory Group's 13F filing for Q2 2026, filed 21 Jul 2026.